. Dans-la-pratique-clinique, analyse du gradient de mastocytes caecum-rectum pourrait permettre de différencier les malades SII-D des malades SII-C, quand la présentation clinique est faite d'une alternance diarrhée-constipation

C. Les, Il n'existait pas non plus de différences entre malades SII et sujets sains Les données de la littérature sont très contradictoires, aussi bien concernant les lymphocytes intra-épithéliaux que les lymphocytes du chorion, De plus notre effectif est limité, par conséquent il est difficile de mettre en évidence des variations compte-tenu de la faible cellularité intra-épithéliale

M. Dapoigny, Irritable bowel syndrome in France, European Journal of Gastroenterology & Hepatology, vol.16, issue.10, 2004.
DOI : 10.1097/00042737-200410000-00008

A. D. Sperber, The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review, Gut, vol.26, issue.1, 2016.
DOI : 10.1136/gutjnl-2015-311240

C. Brun-strang, Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study, European Journal of Gastroenterology & Hepatology, vol.19, issue.12, 2007.
DOI : 10.1097/MEG.0b013e3282f1621b

E. Ahn, Perceived risk as a barrier to appropriate diagnosis of irritable bowel syndrome, World Journal of Gastroenterology, vol.20, issue.48
DOI : 10.1016/j.gie.2005.08.016

G. Barbara, New pathophysiological mechanisms in irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.121, issue.s2, 2004.
DOI : 10.1053/gast.2002.34780

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2004.02036.x/pdf

A. C. Ford and N. J. Talley, Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review, Journal of Gastroenterology, vol.59, issue.suppl, 2011.
DOI : 10.1136/gut.2010.213108

T. Piche, Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators, Gut, vol.58, issue.2, pp.196-201, 2009.
DOI : 10.1136/gut.2007.140806

URL : https://hal.archives-ouvertes.fr/inserm-00332066

M. Vivinus-nebot, Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells, The American Journal of Gastroenterology, vol.19, issue.1, 2012.
DOI : 10.1067/mai.2000.108434

M. Vivinus-nebot, Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation, Gut, vol.19, issue.1 Suppl, pp.744-52, 2014.
DOI : 10.1111/j.1365-2982.2006.00875.x

S. Cornick, A. Tawiah, and K. Chadee, Roles and regulation of the mucus barrier in the gut. Tissue Barriers, p.982426, 2015.

M. K. Tulic, Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction, Gut, vol.53, issue.5, 2016.
DOI : 10.1111/j.1398-9995.1998.tb04994.x

G. Barbara, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome, Gastroenterology, vol.126, issue.3, 2004.
DOI : 10.1053/j.gastro.2003.11.055

S. Buhner, Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome, Gastroenterology, vol.137, issue.4, pp.1425-1459, 2009.
DOI : 10.1053/j.gastro.2009.07.005

G. Barbara, The Immune System in Irritable Bowel Syndrome, Journal of Neurogastroenterology and Motility, vol.17, issue.4, pp.349-59, 2011.
DOI : 10.5056/jnm.2011.17.4.349

C. Cremon, Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome, The American Journal of Gastroenterology, vol.16, issue.7, 2011.
DOI : 10.1097/00042737-200410000-00010

E. Sinagra, Inflammation in irritable bowel syndrome: Myth or new treatment target?, World Journal of Gastroenterology, vol.22, issue.7, pp.2242-55, 2016.
DOI : 10.1111/j.1365-2036.2011.04637.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734999

G. Barbara, A role for inflammation in irritable bowel syndrome? Gut, 2002.

S. P. Dunlop, D. Jenkins, and R. C. Spiller, Age-related decline in rectal mucosal lymphocytes and mast cells, European Journal of Gastroenterology & Hepatology, vol.16, issue.10, 2004.
DOI : 10.1097/00042737-200410000-00010

C. Jacob, Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins, J Biol Chem, issue.2, 2005.

J. H. Park, Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome, Journal of Gastroenterology and Hepatology, vol.81, issue.1, 2006.
DOI : 10.1016/0016-5085(87)90255-1

G. Barbara, Mast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome, Gastroenterology, vol.132, issue.1, 2007.
DOI : 10.1053/j.gastro.2006.11.039

M. Guilarte, Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum, Gut, vol.56, issue.2, 2007.
DOI : 10.1136/gut.2006.100594

S. H. Wang, Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome, World Journal of Gastroenterology, vol.13, issue.45, pp.13-6041, 2007.
DOI : 10.3748/wjg.13.6041

T. Piche, Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome, Gut, vol.57, issue.4, 2008.
DOI : 10.1136/gut.2007.127068

M. M. Wouters, M. Vicario, and J. Santos, The role of mast cells in functional GI disorders, Gut, vol.390, issue.(Suppl 1), pp.155-68, 2016.
DOI : 10.1016/S0014-2999(00)00013-3

B. Mckenna, Is It Really Colitis?, Pathology Case Reviews, vol.9, issue.3, pp.106-114, 2004.
DOI : 10.1097/01.pcr.0000126995.27683.bf

S. Seyedmirzaee, Serum immune biomarkers in irritable bowel syndrome, Clinics and Research in Hepatology and Gastroenterology, vol.40, issue.5, 2016.
DOI : 10.1016/j.clinre.2015.12.013

R. Kirsch and R. H. Riddell, Histopathological alterations in irritable bowel syndrome, Modern Pathology, vol.138, issue.12, pp.1638-1683, 2006.
DOI : 10.1097/00000478-199609000-00008

A. K. Abbas, A. H. Lichtman, and S. Pillai, Cellular and molecular immunology, pp.978-978

H. Tornblom, Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome, Gastroenterology, vol.123, issue.6, 2002.
DOI : 10.1053/gast.2002.37059

R. C. Spiller, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, vol.47, issue.6, pp.47-804, 2000.
DOI : 10.1136/gut.47.6.804

Y. Nasser, Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome, Neurogastroenterology & Motility, vol.128, issue.Suppl., 2014.
DOI : 10.1038/nrgastro.2012.138

R. B. Hiatt and L. Katz, Mast cells in inflammatory conditions of the gastrointestinal tract, Am J Gastroenterol, vol.37, issue.3, pp.541-546, 1962.

A. Akbar, Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain, Gut, vol.57, issue.7, 2008.
DOI : 10.1136/gut.2007.138982

URL : http://gut.bmj.com/content/gutjnl/57/7/923.full.pdf

S. P. Dunlop, D. Jenkins, and R. C. Spiller, Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome, The American Journal of Gastroenterology, vol.127, issue.2, 2003.
DOI : 10.1046/j.1365-2036.1999.00610.x

C. Cremon, Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms, The American Journal of Gastroenterology, vol.121, issue.2, 2009.
DOI : 10.1097/MCG.0b013e31803d0f94

J. K. Beatty, A. Bhargava, and A. G. Buret, Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection, World Journal of Gastroenterology, vol.20, issue.14, pp.20-3976, 2014.
DOI : 10.3748/wjg.v20.i14.3976

URL : http://doi.org/10.3748/wjg.v20.i14.3976